Skip to main content

News

CPS Performance Materials Group Acquires GEO Specialty Chemicals

September 3, 2019
CPS Performance Materials, a diversified specialty chemicals manufacturer of performance polymers, fine chemical and chemical illumination solutions, announced today the acquisition of GEO Specialty Chemicals.  CPS is a portfolio company of Arsenal Capital Partners.  The terms of the acquisition were not disclosed. 
Read More about CPS Performance Materials Group Acquires GEO Specialty Chemicals

Meridian Adhesives Group Acquires Epoxies, Etc.

August 23, 2019
Meridian Adhesives Group announced today the acquisition of Epoxies, Etc., a leading resin formulator of epoxies, urethanes and silicones. 
Read More about Meridian Adhesives Group Acquires Epoxies, Etc.

Arsenal Capital Partners Announces Addition of Mike Bernstein as Operating Partner to its Healthcare Team

August 21, 2019
Arsenal Capital Partners, a leading specialized private equity firm investing in specialty industrials and healthcare companies, announced today the addition of Michael Bernstein to its healthcare team.
Read More about Arsenal Capital Partners Announces Addition of Mike Bernstein as Operating Partner to its Healthcare Team

Polytek® Development Corp. Announces Acquisition of Stone Coat Countertops

August 20, 2019
Polytek, a manufacturer of specialty polymers for mold making and casting applications, announced today the acquisition of Stone Coat Countertops. Polytek is a portfolio company of Arsenal Capital Partners.
Read More about Polytek® Development Corp. Announces Acquisition of Stone Coat Countertops

Caprion Biosciences and HistoGeneX Unite Businesses to Create Global Leader in Immune Monitoring and Biomarker Development

July 31, 2019
Caprion Biosciences and HistoGeneX announced today they have agreed to combine their respective businesses. The new partnership creates a global leader in immune monitoring, protein characterization, and tissue pathology solutions for immunotherapy and drug development.
Read More about Caprion Biosciences and HistoGeneX Unite Businesses to Create Global Leader in Immune Monitoring and Biomarker Development